Clinical Trials on Relapse Remitting Multiple Sclerosis
Total 3423 results
-
University of MalagaUnknownRelapsing-remitting Multiple SclerosisSpain
-
Assiut UniversityUnknownSimvastatin Multiple Sclerosis
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
Galapagos NVTerminatedClinically Isolated Syndrome | Acute Exacerbation of Remitting Relapsing Multiple SclerosisBelgium, Poland, Germany
-
University Hospital, MontpellierCompletedProgressive Multiple Sclerosis | Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | ControlsFrance
-
University of South FloridaGenentech, Inc.Active, not recruitingPathologic Processes | Nervous System Diseases | Immune System Diseases | Multiple Sclerosis | Demyelinating Diseases | Autoimmune Diseases | Relapsing Remitting Multiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
University of LouisvilleBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Relapsing-remittingUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Relapsing-RemittingSweden, Germany
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)Czech Republic, Switzerland
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMultiple Sclerosis | Remitting Relapsing Multiple SclerosisFrance
-
University Hospital, MontpellierRecruiting
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruiting
-
University of LouisvilleRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
Mapi Pharma Ltd.Active, not recruiting
-
Ospedale Policlinico San MartinoActive, not recruiting
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingRelapsing Remitting Multiple SclerosisChina, United States, Ukraine, Poland
-
Johns Hopkins UniversityGlaxoSmithKlineTerminatedMultiple SclerosisUnited States
-
University of MichiganCompleted
-
TG Therapeutics, Inc.Completed
-
Assiut UniversityCompletedRelapsing Remitting Multiple SclerosisEgypt
-
Firat UniversityCompletedRelapsing Remitting Multiple SclerosisTurkey
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Providence Health & ServicesGenentech, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
Banner Life Sciences LLCWithdrawnRelapsing Remitting Multiple Sclerosis
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Teva Pharmaceutical Industries, Ltd.TerminatedRelapsing Remitting Multiple SclerosisCzechia, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
University of ChicagoGenzyme, a Sanofi CompanyCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
Charite University, Berlin, GermanyGerman Research Foundation; Pfizer; German Federal Ministry of Education and...CompletedRelapsing Remitting Multiple Sclerosis
-
Johns Hopkins UniversityCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Novartis PharmaceuticalsCompletedMultiple SclerosisRussian Federation, Ukraine, Czech Republic
-
Isfahan University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
BiogenGB Pharma Services & Consulting s.r.l.Withdrawn
-
Rocky Mountain MS Research Group, LLCBiogenCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedMultiple SclerosisColombia, Panama, Peru, Brazil, Jordan, Malaysia, Mexico, Argentina
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
Neurotec PharmaAdvancell - Advanced In Vitro Cell Technologies, S.A.CompletedRelapsing Remitting Multiple SclerosisSpain, Germany
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Anna TsakiriSanofiWithdrawnRelapsing Remitting Multiple SclerosisDenmark
-
EMD SeronoMerck Serono International SACompletedMultiple Sclerosis, Relapsing-remitting
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States